Validity of the Quality of Well-Being Scale for persons with human immunodeficiency virus infection. HNRC Group. HIV Neurobehavioral Research Center
- PMID: 7792372
- DOI: 10.1097/00006842-199503000-00006
Validity of the Quality of Well-Being Scale for persons with human immunodeficiency virus infection. HNRC Group. HIV Neurobehavioral Research Center
Abstract
To evaluate the validity of the Quality of Well-Being Scale (QWB) for studies of patients with human immunodeficiency virus (HIV) disease, 514 men were studied who were divided among four categories: Centers for Disease Control and Prevention (CDC) Group A (N = 272), CDC-B (N = 81), CDC-C (N = 47), and uninfected male controls (N = 114). The QWB and a variety of medical, neuropsychological, and biochemical measures were administered to all participants. When QWB scores were broken down by HIV group, the CDC-C group was significantly lower (.614) than the CDC-B (.679), CDC-A (.754), or control group (.801). The difference between Groups CDC-C and CDC-A was about .14 units of well-being, which suggests that individuals lose 1/7 equivalents of 1 well year of life for each year they are in Group CDC-C in comparison to the asymptomatic group (Group CDC-A). In comparison to the controls, this would equal a 1-year of life loss for each seven infected individuals. The QWB was shown to be significantly associated with CD4+ lymphocytes (p < .001), clinician ratings of neuropsychological impairment (p < .04), neurologists ratings of dysfunction (p < .001), and all subscales of the Profile of Mood States. Baseline QWB scores were significant prospective predictors of death over a median follow-up time of 30 months. Multivariate models demonstrated high covariation between predictors of QWB. It was concluded that the QWB is a significant correlate of biological, neuropsychological, neurological, psychiatric, and mortality outcomes for male HIV-infected patients.
Similar articles
-
The Quality of Well-Being scale in asymptomatic HIV-infected patients. HNRC Group. HIV Neural Behavioral Research Center.Qual Life Res. 1997 Aug;6(6):507-14. doi: 10.1023/a:1018456031659. Qual Life Res. 1997. PMID: 9330551
-
The HNRC 500--neuropsychology of HIV infection at different disease stages. HIV Neurobehavioral Research Center.J Int Neuropsychol Soc. 1995 May;1(3):231-51. doi: 10.1017/s1355617700000230. J Int Neuropsychol Soc. 1995. PMID: 9375218
-
A longitudinal study of the neuropsychiatric consequences of HIV-1 infection in gay men. II. Psychological and health status at baseline and at 12-month follow-up.Psychol Med. 1994 Nov;24(4):897-904. doi: 10.1017/s0033291700028981. Psychol Med. 1994. PMID: 7892357
-
Neuropsychological studies of asymptomatic human immunodeficiency virus-type-1 infected individuals. The HNRC Group. HIV Neurobehavioral Research Center.J Int Neuropsychol Soc. 1995 May;1(3):304-15. doi: 10.1017/s1355617700000308. J Int Neuropsychol Soc. 1995. PMID: 9375225 Review.
-
Children and adolescents living with HIV and AIDS: a review.J Child Psychol Psychiatry. 2000 Jan;41(1):81-96. J Child Psychol Psychiatry. 2000. PMID: 10763677 Review.
Cited by
-
Evidence for reliability, validity and usefulness of the Medical Outcomes Study HIV Health Survey (MOS-HIV).Qual Life Res. 1997 Aug;6(6):481-93. doi: 10.1023/a:1018451930750. Qual Life Res. 1997. PMID: 9330549 Review.
-
The Quality of Well-Being scale in asymptomatic HIV-infected patients. HNRC Group. HIV Neural Behavioral Research Center.Qual Life Res. 1997 Aug;6(6):507-14. doi: 10.1023/a:1018456031659. Qual Life Res. 1997. PMID: 9330551
-
Quality of well-being outcomes in the National Emphysema Treatment Trial.Chest. 2015 Feb;147(2):377-387. doi: 10.1378/chest.14-0528. Chest. 2015. PMID: 25340383 Free PMC article. Clinical Trial.
-
Validation of the World Health Organization quality of life instrument in patients with HIV infection.Qual Life Res. 2002 Dec;11(8):753-62. doi: 10.1023/a:1020870402019. Qual Life Res. 2002. PMID: 12482159
-
The age-related trajectory of visual attention neural function is altered in adults living with HIV: A cross-sectional MEG study.EBioMedicine. 2020 Nov;61:103065. doi: 10.1016/j.ebiom.2020.103065. Epub 2020 Oct 21. EBioMedicine. 2020. PMID: 33099087 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials